GER
Wiebke Loebker
Innovation
health care
digitalization
horizon scanning
change management
Personal Assistant of the President; Federal Institute of Drugs and Medical Products; Head of Innovation Office, Change Management Staff Unit, Germany
Federal Institute of Drugs and Medical Product

leadership vision

As a healthcare leader, it is my responsibility to realize our vision, which is based on excellence in patient(centric) care and innovation. I lead my team through open communication, mutual respect, trust and empathy. I create a motivating and inspiring environment of empowerment, collaboration and openness to change, ensuring that the team has the skills and knowledge neccessary to achieve their full potential - and to continously improve patient care and outcomes in this dynamic landscape.

my story

Health knows no borders - that's why I benefit from the exchange on challenges and opportunities in the health sector from many different perspectives, in order to be able to help shape tomorrow's health beyond my own horizon.

about me

Wiebke Antonia Löbker is the Head of Innovation Office, Scientific Advice and Changemanagement at the Federal Institute for Drugs and Medical Devices (BfArM) and the personal advisor to the president of the BfArM. She gained her Ph.D. degree in pharmacology from the Freie Universität Berlin, Germany after studying pharmacy in Berlin, Germany. Before joining the BfArM in 2016, she was a consultant and team coordinator for the area of metabolic, respiratory and cardiovascular diseases with a focus on early benefit assessment („health technology assessment") of innovative medicines in the Department of Medicinal Products of the Federal Joint Committee, Berlin. She is a member of the EU Innovation Network (EU-IN) and a representative in the Permanent Secretariat of the Heads of Medicines Agencies (HMA), where she is involved in strategy development and regulatory support for innovation for a patient-centered healthcare ecosystem, not only at national but also at European level.

more fellows

GBR
Timothy Taylor
NHSEI Midlands
Timothy Taylor
Associate Medical Director, NHSEI Midlands; Consultant Neuroradiologist, Nottingham University Hospitals NHS Trust, United Kingdom
GER
Marc Augustin
Protestant University of Applied Sciences
Marc Augustin
Professor, Protestant University of Applied Sciences Bochum, Germany
GBR
Rachel Carey
Zinc
Rachel Carey
Chief Missions and Science Officer, Zinc, United Kingdom
GBR
Rishi Das Gupta
Health Innovation Network (HIN)
Rishi Das Gupta
Chief Executive, Health Innovation Network (HIN), United Kingdom
GBR
Harpreet Sood
Health Education England
Harpreet Sood
NHS Primary Care Doctor and VP Primary Care, Huma; Board Member, Health Education England, United Kingdom
GBR
Rupert Suckling
Doncaster Council
Rupert Suckling
Director of Public Health, Doncaster Council in the North of England; Board Member, Association of Directors of Public Health, UK
GBR
Richard Stubbs
Yorkshire & Humber AHSN
Richard Stubbs
Chief Executive, Health Innovation Yorkshire & Humber and Chair, National Health Innovation Network, United Kingdom
GER
Lorena Dini
Charité Universitätsmedizin Berlin
Lorena Dini
Senior Researcher, Charité Universitätsmedizin Berlin, Germany
GER
Wiebke Loebker
Federal Institute of Drugs and Medical Product
Wiebke Loebker
Personal Assistant of the President; Federal Institute of Drugs and Medical Products; Head of Innovation Office, Change Management Staff Unit, Germany
SUI
Saskia De Gani
Careum Stiftung
Saskia De Gani
Department Head, Careum Center for Health Literacy, Careum Stiftung, Switzerland
GBR
Helen Crimlisk
Sheffield Health & Social Care NHS Foundation Tr
Helen Crimlisk
Consultant Psychiatrist and Deputy Medical Director, Sheffield Health and Social Care NHS Foundation Trust, United Kingdom
GER
Anna Babette Stier
Federal Ministry of Health
Anna Babette Stier
Head of Directorate for Health Protection and Sustainability, Federal Ministry of Health, Germany
SUI
Oliver Reich
SWICA Health Organisation
Oliver Reich
Director, santé24, Switzerland
GBR
Adam Doyle
Sussex Clinical Commissioning Groups
Adam Doyle
Chief Executive Officer/National Director - System Development, NHS Sussex/NHS England, United Kingdom
SUI
Nicola von Lutterotti
Self-employed
Nicola von Lutterotti
President of the Board of Trustees, the Max-Planck Institute for Immunobiology and Epigenetics, Freiburg; Science Writer; Author, Germany
GER
Ulrike Streit
University Hospital Frankfurt
Ulrike Streit
Managing senior physician in radiology, The Klinikum rechts der Isar, The University Hospital of the Technical University of Munich, Germany

Meet the Partners

Sciana — The Health Leaders Network is a joint initiative of The Health Foundation, Careum and the Bosch Health Campus, in partnership with Salzburg Global.